Market Research Logo

Georgia Pharmaceuticals and Healthcare Report Q4 2017

Georgia Pharmaceuticals and Healthcare Report Q4 2017

BMI View:

Georgia continues to represent an interesting proposition for well-targeted multinational efforts, as the authorities remain committed to the improvement of healthcare outcomes and universal healthcare coverage. However, factors such as its small population size, government support for domestic production, and use of generic medicines will clearly constrain market growth.

Headline Expenditure Projections

Pharmaceuticals: GEL1.19bn (USD516mn) in 2016 to GEL1.31bn (USD568mn) in 2017; 10.1% in local currency terms and 10.1% in US dollar terms. Forecast unchanged from previous quarter.

Healthcare: GEL2.31bn (USD1.00bn) in 2016 to GEL2.41bn (USD1.05bn) in 2017; 4.2% in local currency terms and 4.2% in US dollar terms. Forecast unchanged from previous quarter.

Latest Updates

In August 2017, Gilead was awarded the Golden Fleece Order by the Georgian prime minister. This was to recognise its contribution to the eradication and prevention of Hepatitis C and its participation in the 'Georgia without Hepatitis C' programme, launched in 2015.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Georgia 2015-2021)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Georgia 2013-2021)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Georgia 2013-2021)
Table: Government Healthcare Expendditure Trends, Historical Data And Forecasts (Georgia 2013-2021)
Table: Private Healthcare Expenditure Trends, Historical Data And Fotrcasts (Georgia 2012-2020)
Industry Risk Reward Index
Central And Eastern Europe Pharmaceuticals: A Mixture Of Opportunities
Regulatory Review
Pricing Regime
Reimbursement Regime
Table: Medicine Reimbursement Tiers
Market Overview
Healthcare Sector
Research And Development
Clinical Trials
Epidemiology
Competitive Landscape
Research-Based Industry
Table: Multinational Market Activity
Generic Drugmakers
Pharmaceutical Distribution And Retail
Demographic Forecast
Table: Population Headline Indicators (Georgia 1990-2025)
Table: Key Population Ratios (Georgia 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Georgia 1990-2025)
Table: Population By Age Group (Georgia 1990-2025)
Table: Population By Age Group % (Georgia 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Table: Indicators - Rationale And Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report